Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors
The term monoclonal B-cell lymphocytosis (MBL) describes the presence of a clonal B cell population with a count of less than 5 × 109/L and no symptoms or signs of disease. Based on the B cell count, MBL is further classified into 2 distinct subtypes: ‘low-count’ and ‘high-count’ MBL. High-count MBL...
Main Authors: | Chrysi Galigalidou, Laura Zaragoza-Infante, Anastasia Iatrou, Anastasia Chatzidimitriou, Kostas Stamatopoulos, Andreas Agathangelidis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.769612/full |
Similar Items
-
B Cell Receptor Immunogenetics in B Cell Lymphomas: Immunoglobulin Genes as Key to Ontogeny and Clinical Decision Making
by: Katerina Gemenetzi, et al.
Published: (2020-01-01) -
Editorial: Role of the antigen receptor in the pathogenesis of B-cell lymphoid malignancies
by: Andreas Agathangelidis, et al.
Published: (2023-03-01) -
Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL
by: Gonzalo Blanco, et al.
Published: (2018-06-01) -
Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identity
by: Electra Sofou, et al.
Published: (2022-12-01) -
T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia
by: Elisavet Vlachonikola, et al.
Published: (2021-06-01)